Efficacy and safety of cladribine in adult pulmonary Langerhans cell histiocytosis: a phase II study

Amira Benattia, Gwenaël Lorillon, Constance de Margerie-Mellon, Laetitia Vercellino, Philippe Bonniaud, Charles-Hugo Marquette, Sylvie Chevret, Abdellatif Tazi

Open source

DOI
10.1183/13993003.01464-2025
Published
2026-05-29
Container
European Respiratory Journal
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1183/13993003.01464-2025,
  title = {Efficacy and safety of cladribine in adult pulmonary Langerhans cell histiocytosis: a phase II study},
  author = {Amira Benattia and Gwenaël Lorillon and Constance de Margerie-Mellon and Laetitia Vercellino and Philippe Bonniaud and Charles-Hugo Marquette and Sylvie Chevret and Abdellatif Tazi},
  year = {2026},
  journal = {European Respiratory Journal},
  doi = {10.1183/13993003.01464-2025},
  url = {https://doi.org/10.1183/13993003.01464-2025}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of cladribine in adult pulmonary Langerhans cell histiocytosis: a phase II study
AU  - Amira Benattia
AU  - Gwenaël Lorillon
AU  - Constance de Margerie-Mellon
AU  - Laetitia Vercellino
AU  - Philippe Bonniaud
AU  - Charles-Hugo Marquette
AU  - Sylvie Chevret
AU  - Abdellatif Tazi
PY  - 2026
JO  - European Respiratory Journal
DO  - 10.1183/13993003.01464-2025
UR  - https://doi.org/10.1183/13993003.01464-2025
ER  - 

APA

Benattia, A., Lorillon, G., Margerie-Mellon, C. D., Vercellino, L., Bonniaud, P., Marquette, C., Chevret, S., & Tazi, A. (2026). Efficacy and safety of cladribine in adult pulmonary Langerhans cell histiocytosis: a phase II study. European Respiratory Journal. https://doi.org/10.1183/13993003.01464-2025

Source records